Used in pharmaceutical research as a key intermediate in the synthesis of selective enzyme inhibitors, particularly targeting proteases involved in inflammatory and oncological pathways. Its structural features enable strong binding interactions with specific active sites, making it valuable in the development of potential anticancer and anti-inflammatory agents. Also employed in studies involving chiral recognition due to its stereochemistry, supporting advances in asymmetric synthesis and drug design.